Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2000-10-30
pubmed:abstractText
The cytochrome P450c17alpha enzyme functions in the steroid biosynthesis pathway, and altered endogenous steroid hormone levels have been reported to be associated with a T to C polymorphism in the 5' promoter region of the CYP17 gene. Because steroid hormone exposure is known to influence breast cancer risk, we conducted a population-based, case-control-family study to assess the relationship between the CYP17 promoter polymorphism and early-onset breast cancer.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0027-8874
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1674-81
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11036113-Adult, pubmed-meshheading:11036113-Age Factors, pubmed-meshheading:11036113-Age of Onset, pubmed-meshheading:11036113-Alleles, pubmed-meshheading:11036113-Australia, pubmed-meshheading:11036113-Breast Neoplasms, pubmed-meshheading:11036113-Case-Control Studies, pubmed-meshheading:11036113-DNA, Neoplasm, pubmed-meshheading:11036113-DNA Primers, pubmed-meshheading:11036113-Female, pubmed-meshheading:11036113-Genes, BRCA1, pubmed-meshheading:11036113-Genes, Tumor Suppressor, pubmed-meshheading:11036113-Genotype, pubmed-meshheading:11036113-Humans, pubmed-meshheading:11036113-Logistic Models, pubmed-meshheading:11036113-Mutation, pubmed-meshheading:11036113-Polymerase Chain Reaction, pubmed-meshheading:11036113-Polymorphism, Genetic, pubmed-meshheading:11036113-Promoter Regions, Genetic, pubmed-meshheading:11036113-Risk, pubmed-meshheading:11036113-Steroid 17-alpha-Hydroxylase
pubmed:year
2000
pubmed:articleTitle
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
pubmed:affiliation
Cancer Unit, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research, and The University of Queensland, Brisbane, Australia. mandyS@qimr.edu.au
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't